TRIUMPH GRP INC. DL-,001/ US8968181011 /
10/06/2024 14:41:11 | Diferencia 0.000 | Volumen | Bid14:41:11 | Ask14:41:11 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
13.800EUR | 0.00% | - Volumen de negocios: - |
13.800Volumen de oferta: - | 14.100Tamaño/ Volumen/ Formato de Ask: - | 1.07 mil millonesEUR | - | - |
GlobeNewswire
14:40
SELLAS Announces Completion of Enrollment and Initial Positive Data in Phase 2a Trial of SLS009 in r...
GlobeNewswire
14:35
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Stormer Santana, Director of Sales a...
GlobeNewswire
14:32
Publication of an article in Nature's Scientific Reports describing the quantification of novel radi...
GlobeNewswire
14:30
NewtekOne, Inc. CEO, Barry Sloane, to Attend the 25th Annual KBW Community Bank Investor Conference ...
GlobeNewswire
14:30
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patie...
GlobeNewswire
14:30
DFCU Financial Completes Acquisition of MidWestOne Bank’s Florida Operations in Naples and Fort Myer...
GlobeNewswire
14:30
C-Bond Systems Continues to Expand its Installation Base with more than 200 Schools, Commercial and ...
GlobeNewswire
14:30
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
GlobeNewswire
14:30
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWG...
GlobeNewswire
14:30
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire
14:30
Presentation at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting High...
GlobeNewswire
14:30
Optery Receives 2024 Intellyx Digital Innovator Award for Its Effectiveness At Reducing Security Inc...
GlobeNewswire
14:30
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página